Roles of intrinsic angiogenesis inhibitor, vasohibin, in cervical carcinomas
Open Access
- 26 November 2010
- journal article
- Published by Wiley in Cancer Science
- Vol. 102 (2) , 446-451
Abstract
The aim of the present study is to clarify the critical roles of vasohibin in cervical carcinomas. We investigated the expression ratios of vasohibin and vascular endothelial growth factor (VEGF) receptor‐2 on endothelium and microvessel density, lymphatic vessel density (LVD) by immunohistochemistry. Sixty‐one squamous cell carcinoma (SCC), 18 mucinous adenocarcinoma (Adenocarcinoma), 38 carcinoma in situ (CIS), and 35 normal cervical epithelium were collected. We investigated the expression of vasohibin and compared it with the expression of VEGF receptor‐2 (VEGFR‐2, KDR/flk‐1), and CD34 in the stromal endothelium. Expression of VEGF was counted using the histological score (H score). D2‐40 was used as a marker for lymphatic endothelial cells to investigate LVD. The microvessel density of the normal cervical epithelium was significantly lower than that of CIS, SCC, and Adenocarcinoma (P < 0.05). The expression ratio of vasohibin in the normal cervical epithelium was significantly lower than that of SCC and Adenocarcinoma (P < 0.05). The expression ratio of VEGFR‐2 of the normal cervical epithelium was significantly lower than that of SCC and Adenocarcinoma (P < 0.05). The LVD of the normal cervical epithelium was significantly lower than that of CIS, SCC, and Adenocarcinoma (P < 0.05). For normal cervical epithelium, CIS, and SCC, there was a moderate correlation between the expression percentage of vasohibin and the expression percentage of VEGFR‐2 (P < 0.05, r2 = 0.3018). This is the first study to elucidate the correlation between the expression of vasohibin in the stromal endothelial cells and the expression of VEGFR‐2 in human cervical carcinomas. (Cancer Sci 2011; 102: 446–451)Keywords
This publication has 29 references indexed in Scilit:
- Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretionJournal of Cell Science, 2010
- Regulation of Tumor Angiogenesis by EZH2Cancer Cell, 2010
- Vasohibin-1 Expression in Endothelium of Tumor Blood Vessels Regulates AngiogenesisThe American Journal of Pathology, 2009
- Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group studyGynecologic Oncology, 2009
- Clinical implications of increased lymph vessel density in the lymphatic metastasis of early-stage invasive cervical carcinoma: a clinical immunohistochemical method studyBMC Cancer, 2009
- Vasohibin‐1 in human breast carcinoma: A potential negative feedback regulator of angiogenesisCancer Science, 2009
- Multiple processing forms and their biological activities of a novel angiogenesis inhibitor vasohibinBiochemical and Biophysical Research Communications, 2006
- Angiogenesis in cervical intraepithelial neoplasia and early-staged uterine cervical squamous cell carcinoma: clinical significanceInternational Journal of Gynecological Cancer, 2006
- Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesisExperimental Cell Research, 2006
- Gene regulation of a novel angiogenesis inhibitor, vasohibin, in endothelial cellsBiochemical and Biophysical Research Communications, 2005